Trusted Resources: Education
Scientific literature and patient education texts
Detailed Pedigree Analyses and Prenatal Diagnosis for a Family With Mucopolysaccharidosis Type II
source: BMC medical genomics
year: 2021
authors: Zhang C,Hao S,Meng Z,Hui L,Wang Y,Xuan F,Chen X,Wang X,Zheng F,Zheng L,Zhou B,Wu X,Zhang Q,Cao Z
summary/abstract:Mucopolysaccharidosis type II (MPS II) is an X-linked multisystem disorder caused by mutations in the gene encoding iduronate 2-sulfatase (IDS). The clinical manifestations of MPS II include skeletal deformities, airway obstruction, cardiomyopathy, and neurologic deterioration. MPS II has high genetic heterogeneity disorder, and ~ 658 variants of IDS have been reported.
organization: Gansu Province Maternal and Child Health Care Hospital, Lanzhou, 730050, China.DOI: 10.1186/s12920-021-01027-5
read more
BookmarkRelated Content
-
A 1-Year and 4-Month-Old Child With Mucopolysaccharidoses Type II: A Clinical Case Report From EthiopiaMucopolysaccharidoses (MPSs) are a class...
-
A Guide to Understanding MPS III (Sanfilippo Syndrome)MPS III belongs to a group of inherited ...
-
iPS-Derived Neural Stem Cells for Disease Modeling and Evaluation of Therapeutics for Mucopolysaccharidosis Type IIMucopolysaccharidosis type II (MPS II), ...
-
MPS I: The Importance of Early Diagnosishttps://www.youtube.com/watch?v=dCQzZPso...
-
Denali Therapeutics Announces Continued Progress in DNL310 (ETV:IDS) Program for MPS II (Hunter Syndrome) Supporting...Denali Therapeutics Inc., a biopharmaceu...
-
[Pharmacological Property, Mechanism of Action and Clinical Study Results of Pabinafusp Alfa (Genetical Recombinatio...Mucopolysaccharidosis type II (MPS II) i...
-
Increased Choroidal Thickness in Morquio SyndromeThe purpose of this clinical case report...
Powered by
